Intra-Cellular submitted its application to the FDA for Caplyta’s approval in major depressive disorder, potentially opening ...

The Bipolar Disorder Drugs and Treatment Market is projected to grow at a CAGR of 2.72%, reaching USD 5.8 billion by 2033.

Faye Mitchell felt an unfamiliar sense of hope in late 2023 that her son, Geno, would finally get the treatment he needed. After nearly a decade of false starts, Geno Sargent, 24, was optimistic, too.

GEN highlights six AI-based drug discoverers worthy of note based on pipeline or platform progress, and in one instance, a ...

Edward Scolnick led the development of dozens of medicines while at Merck. His current mission pits him against time and the ...

The overlap between the two is why Kansas City Municipal Court is merging its Mental Health Court and Drug Court to form an ...

A woman with epilepsy has accused the UK's drug safety regulator of failing patients ... “For the majority of patients there ...

Since a schizophrenia drug, the first in decades with an innovative mechanism of action, gained US regulatory approval in ...

Good afternoon, ladies and gentlemen, and welcome to the NRx Pharmaceuticals third-quarter 2024 earnings conference call. (Operator Instructions) This call is being recorded on Monday, November 18, ...

A drug that helps patients with neurological issues walk may also provide a surprising boost for the brain. Researchers at ...

Drug safety relates to the potential for adverse effects related to the administration of drugs. Efforts to establish the safely profile of drugs begin early in their development, with in vitro ...

“We are advancing our SERENITY At-Home trial to pursue the near-term growth opportunity for treating acute agitation ...